Synergy CHC Corp. Increase (Decrease) in Contract with Customer, Liability
Synergy CHC Corp. (SNYR) reported Increase (Decrease) in Contract with Customer, Liability of -$1.53 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2026-05-14
- Synergy CHC Corp. increase (decrease) in contract with customer, liability for the quarter ending 2026-03-31 was -$1.53K.
- Synergy CHC Corp. increase (decrease) in contract with customer, liability for the quarter ending 2025-12-31 was -$328.00, a 101.48% decline year-over-year.
- Synergy CHC Corp. increase (decrease) in contract with customer, liability for the quarter ending 2025-09-30 was -$3.03K.
- Synergy CHC Corp. increase (decrease) in contract with customer, liability for the quarter ending 2025-06-30 was $4.85K.
- Synergy CHC Corp. increase (decrease) in contract with customer, liability for fiscal 2025 was -$22.73K, a 326.13% decline from fiscal 2024.
- Synergy CHC Corp. increase (decrease) in contract with customer, liability for fiscal 2024 was $10.05K, a 11.60% increase from fiscal 2023.
- Synergy CHC Corp. increase (decrease) in contract with customer, liability for fiscal 2023 was $9.01K.
- Synergy CHC Corp. increase (decrease) in contract with customer, liability for fiscal 2019 was -$41.82K, a 189.65% decline from fiscal 2018.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|---|
| 2026-03-31 | -$1.53K 10-Q · filed 2026-05-14 | -$1.85K derived: sum of 2 quarters · filed 2026-05-14 | -$4.89K derived: sum of 3 quarters · filed 2026-05-14 | -$36.00 derived: sum of 4 quarters · filed 2026-05-14 |
| 2025-12-31 | -$328.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | -$3.36K derived: sum of 2 quarters · filed 2026-04-01 | $1.49K derived: sum of 3 quarters · filed 2026-04-01 | -$22.73K 10-K · filed 2026-04-01 |
| 2025-09-30 | -$3.03K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $1.82K derived: sum of 2 quarters · filed 2025-11-13 | -$22.40K 10-Q · filed 2025-11-13 | -$246.00 derived: sum of 4 quarters · filed 2026-05-14 |
| 2025-06-30 | $4.85K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$19.36K 10-Q · filed 2025-08-14 | $2.79K derived: sum of 3 quarters · filed 2026-05-14 | -$6.37K derived: sum of 4 quarters · filed 2026-05-14 |
| 2025-03-31 | -$24.22K 10-Q · filed 2026-05-14 | -$2.06K derived: sum of 2 quarters · filed 2026-05-14 | -$11.22K derived: sum of 3 quarters · filed 2026-05-14 | -$27.10K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $22.15K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $13.00K derived: sum of 2 quarters · filed 2026-04-01 | -$2.88K derived: sum of 3 quarters · filed 2026-04-01 | $10.05K 10-K · filed 2026-04-01 |
| 2024-09-30 | -$9.15K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$25.03K derived: sum of 2 quarters · filed 2025-11-13 | -$12.10K 10-Q · filed 2025-11-13 | -$6.53K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | -$15.88K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$2.95K 10-Q · filed 2025-08-14 | $2.62K derived: sum of 3 quarters · filed 2025-08-14 | |
| 2024-03-31 | $12.93K 10-Q · filed 2025-05-15 | $18.50K derived: sum of 2 quarters · filed 2025-05-15 | ||
| 2023-12-31 | $5.57K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $9.01K 10-K · filed 2025-03-31 | ||
| 2023-09-30 | $3.43K 10-Q · filed 2024-12-06 | |||
| 2020-03-31 | $9.25K 10-Q · filed 2020-06-29 | $7.19K derived: sum of 2 quarters · filed 2020-06-29 | -$19.91K derived: sum of 3 quarters · filed 2020-06-29 | -$67.24K derived: sum of 4 quarters · filed 2020-06-29 |
| 2019-12-31 | -$2.06K derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-29 | -$29.16K derived: sum of 2 quarters · filed 2020-04-29 | -$76.49K derived: sum of 3 quarters · filed 2020-04-29 | -$41.82K 10-K · filed 2020-04-29 |
| 2019-09-30 | -$27.11K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$74.43K derived: sum of 2 quarters · filed 2019-11-14 | -$39.76K 10-Q · filed 2019-11-14 | -$38.09K derived: sum of 4 quarters · filed 2020-06-29 |
| 2019-06-30 | -$47.32K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | -$12.66K 10-Q · filed 2019-08-13 | -$10.99K derived: sum of 3 quarters · filed 2020-06-29 | -$3.85K derived: sum of 4 quarters · filed 2020-06-29 |
| 2019-03-31 | $34.66K 10-Q · filed 2020-06-29 | $36.33K derived: sum of 2 quarters · filed 2020-06-29 | $43.47K derived: sum of 3 quarters · filed 2020-06-29 | $77.58K derived: sum of 4 quarters · filed 2020-06-29 |
| 2018-12-31 | $1.67K derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-29 | $8.81K derived: sum of 2 quarters · filed 2020-04-29 | $42.92K derived: sum of 3 quarters · filed 2020-04-29 | $46.65K 10-K · filed 2020-04-29 |
| 2018-09-30 | $7.14K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $41.25K derived: sum of 2 quarters · filed 2019-11-14 | $44.98K 10-Q · filed 2019-11-14 | |
| 2018-06-30 | $34.11K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | $37.84K 10-Q · filed 2019-08-13 | ||
| 2018-03-31 | $3.73K 10-Q · filed 2019-05-03 | |||
| 2017-12-31 | -$32.94K 10-K · filed 2019-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |